Current Advances in Ankylosing Spondylitis: Application to Clinical Practice

SmartMobile(TM)

Premiere Date: Monday, October 15, 2018

This activity offers CE credit for:

  1. Physicians (CME)
  2. Other

All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™

Credit Expiration Date: Wednesday, October 16, 2019

Begin Activity

Faculty


Allan Gibofsky, MD, JD, MACR, FACP, FCLM Allan Gibofsky, MD, JD, MACR, FACP, FCLM 
Professor of Medicine, Healthcare Policy and Research
Weill Medical College of Cornell University
Attending Rheumatologist
Hospital for Special Surgery
New York, NY

Statement of Need

Ankylosing spondylitis (AS) is a chronic, inflammatory arthritis that effects the axial skeleton. The aging population combined with a declining rheumatology workforce has led to limited access to specialty care, with the condition largely managed in primary care. AS is also challenging to diagnose, having the longest diagnostic delay among other rheumatic diseases. With recent studies showing that patients with shorter disease duration have better response to treatment, this diagnostic delay may cause patients to miss the chance of early appropriate treatment and therefore have poorer prognosis, including disability, limitation of spinal and hip movements, pain, poor quality of life, and poor functional status.

Recognizing key clinical features, classification criteria, and diagnostic tests is critical in reducing diagnosis delays. This CME Outfitters mobile case series is designed to help primary care clinicians increase timely and appropriate treatment initiation for patients with AS.

Learning Objectives

At the end of this CE activity, participants should be able to:

  • Apply the current classification criteria for early and accurate diagnosis of AS.
  • Integrate targeted therapies of AS to improve patient outcomes.

Financial Support

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Target Audience

Primary care physicians, internists, rheumatologists, physician assistants, nurse practitioners, nurses, and pharmacists who treat patients with ankylosing spondylitis.

Credit Information

CME Credit (Physicians):
CME Outfitters, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CME Outfitters, LLC designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Note to Physician Assistants: AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education.

Note to Nurse Practitioners: Nurse practitioners can apply for AMA PRA Category 1 CreditTM through the American Academy of Nurse Practitioners (AANP). AANP will accept AMA PRA Category 1 CreditTM from organizations accredited by the Accreditation Council for Continuing Medical Education. Nurse Practitioners can also apply for credit through their state boards.

Post-tests, credit request forms, and activity evaluations must be completed online at www.cmeoutfitters.com/TST28441 (requires free account activation), and participants can print their certificate or statement of credit immediately (75% pass rate required). This website supports all browsers except Internet Explorer for Mac. For complete technical requirements and privacy policy, visit www.neurosciencecme.com/technical.asp.

Disclosure Declaration

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Gibofsky reports that he is on the speakers bureau for AbbVie Inc.; Celgene Corporation; Merck & Co., Inc.; Pfizer Inc. He is a consultant for AbbVie Inc.; Celgene Corporation; Merck & Co., Inc.; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.; Samumed, LLC; Sandoz. He is a stock shareholder for Abbvie Inc.; Bristol-Myers Squibb Company; Johnson & Johnson Pharmaceutical Research & Development, L.L.C.; Pfizer Inc.; Regeneron Pharmaceuticals, Inc.

Jan Perez (planning committee) has no disclosures to report.

Shari Tordoff (planning committee) has no disclosures to report.

Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.

Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.

Questions about this activity? Call us at 877.CME.PROS (877.263.7767).


This document was last modified on:

QS-006-110718-45